5329232025-01-012025-03-315329232025-03-315329232024-03-315329232024-04-012025-03-315329232025-01-012025-03-31in-capmkt:OtherExpenses1Member5329232025-01-012025-03-31in-capmkt:OtherExpenses2Member5329232024-04-012025-03-31in-capmkt:OtherExpenses1Member5329232024-04-012025-03-31in-capmkt:OtherExpenses2Member5329232025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15329232025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25329232025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35329232025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss45329232025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss55329232024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15329232024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25329232024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35329232024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss45329232024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss55329232025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15329232025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25329232025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss35329232025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss45329232024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15329232024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25329232024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss35329232024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss45329232025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares532923RGLNOTLISTEDINE722H01024RENAISSANCE GLOBAL LIMITEDMain BoardEquity2024-04-012025-03-312025-05-302025-05-27INRLakhsQuarterlyFourth quarterSingle segmentJewellery2025-05-3016:00:002025-05-3018:10:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated514400700025821000516982800020044390001945533000-5309260003332560001234740008390600010100890004969771000200057000020005700026657000-53949000-272920000227349000000022734900051114000278463000250520000-23171000301635000-2317100021446100022.392.37002.392.37NOTES : <BR> 1) The above Audited consolidated financial results have been prepared in accordance with applicable Indian Accounting Standard as prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations <BR> <BR> 2) The above Audited Consolidated financial Results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on May 30, 2025. <BR> <BR> <BR> 3) The Group is engaged primarily in the business of 'Jewellery' and hence there is no separate reportable segment within the criteria defined under Indian Accounting Standard (Ind AS) -108 'Operating Segments'. <BR> <BR> 4) During the quarter/year under review, the Company: <BR> a) has acquired common stocks of RD2C Ventures Inc (RD2C), which was a step-down subsidiary of RGL. Pursuant to this acquisition and following the repurchase of Common Stocks by RD2C from Verigold Jewellery FZCO (VJFZCO), RD2C has become a direct wholly owned subsidiary of Renaissance Global limited (RGL). <BR> b) has acquired, through RD2C Ventures Inc., USA, 38.7% Class A – common stocks of Jean Dousset LLC, USA, having 1:2 voting rights. <BR> c) has acquired 97% shareholding of Verigold Jewellery India Private Limited (VJIPL). <BR> Accordingly, the financial statements of RD2C, Jean Dousset and VJIPL have been consolidated with RGL. <BR> <BR> 5) During the quarter under review, the Company has also incorporated a new subsidiary in India viz. Renaissance Retail Limited to carry on the business of Jewellery Retail through online e-commerce jewellery websites as well as through offline Jewellery stores. <BR> <BR> 6) After the end of financial year, the Board of Director at its meeting held on April 14, 2025 has approved the closure of manufacturing unit at the Bhavnagar, Gujarat w.e.f April 15,2025 for rebalancing the Company’s manufacturing capacities in line with current product mix and manufacturing requirements of the RGL Group. <BR> 7) During the financial year, RGL has issued and allotted 1,08,99,539 number of equity shares via preferential allotment on 20th December 2024 to 146 members and a total of1,99,500 number of shares were allotted pursuant to eligible members exercising ESOPs granted under RGL ESOP scheme 2021. The total number of ordinary equity shares outstanding as on March 31, 2025 is 10,72,30,471 after the above preferential allotment and ESOP exercises. <BR> <BR> 8) Figures pertaining to last quarter are balancing figures between audited figures in respect of full financial year and published and reviewed year-to-date figures up to the end of third quarter of the relevant financial year. <BR> <BR> 9) The figures for the previous quarters / year have been re-group/reclassified wherever necessary. <BR> 2024-04-012025-03-31AuditedConsolidated20809804000809150002089071900099489090004936001000-81942300012653490005206090003015630003885705000200387130008520060000852006000178738000-6361000011512800007368780000000736878000213125000950003000761505000-24627000974630000-24627000214461000207.687.63007.687.63Foreign Exchange (Gain) / Loss (net)48136000Other Expenditure961953000Foreign Exchange (Gain) / Loss (net)75632000Other Expenditure3810073000203147900050000009742200005832000014270000038270000142320003310610003835630003618350003920000381526400096476240009604510007080491000105128600040689000030494000427700009572382000036046700019580473000002339573700021446100013695765000139102260003131160001422334200017738500000013467200001524105000317600000015272810004979183000106060001920927000193153300037959000072903060002678020002822000058786000076451140000091723950002339573700052060900074252000-2268867000002232940000002535600000003015630000-1374200000013362700040600003372500000000596190000-753870000981360000001107410000-12605000006690140009882280000000121307000310852000000000000000000004060000384300000-398536000-86480500000000015179870000193865000017400900004579760000336271000141613800053872800005387280005125580001051286000Re-measurement gains (losses) on defined benefit plans-4555000Equity instruments through other comprehensive income-46023000Mutual fund equity instruments through other comprehensive income-85000Income tax effect on above2042000Gain on bargain purchase (net of Tax)0-48621000Re-measurement gains (losses) on defined benefit plans-4555000Equity instruments through other comprehensive income95719000Mutual fund equity instruments through other comprehensive income136000Income tax effect on above2220000Gain on bargain purchase (net of Tax)09352000000Fair value changes on derivatives disgnated as cash flow hedges86686000Mutual fund debts instruments through other comprehensive income0Income tax effect on above-21817000Exchange differences on transaction of foreign operations3486600099735000Fair value changes on derivatives disgnated as cash flow hedges-46604000Mutual fund debts instruments through other comprehensive income0Income tax effect on above11729000Exchange differences on transaction of foreign operations1544800001196050000051114000213125000AuditedtrueChaturvedi and Shah LLP, Chartered Accountantstrue2026-06-30